October 17, 2017

Context Therapeutics presented at the annual BIO Investor Forum on October 17-18, 2017. This event brings together blue chip institutional investors and emerging companies. 150 companies are selected to present, almost all of which are late stage private or public companies. 10 slots are reserved for company’s that have raised < $25M of capital and Context was selected as one of those 10 companies.

Visit the BIO Investor Forum Site